Surrozen Competitors and Similar CompaniesClear all
Surrozen's competitors and similar companies include CSL Behring, Biogen, Chiesi Group and Alembic Pharmaceuticals.
 Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. |  Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates | |||
Founding Date | Founding Date 2016 | Founding Date 1904 | Founding Date 1978 | Founding Date 1935 | Founding Date 2010 |
Type | Type Public | Type Subsidiary | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations South San Francisco, US HQ | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN |
Employees | Employees 4410% increase | Employees 7,5692% decrease | Employees 7,605 | Employees 5,8541% increase | Employees 14,858 |
Valuation ($) | Valuation ($) 30.5 m | Valuation ($) N/A | Valuation ($) 26.7 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) €2.4b (Y, 2021) | Revenue (est.) ₹73.4b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) | Cost of goods N/A | Cost of goods ₹19.8b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit $4.5b (FY, 2020) | Gross profit $7.5b (FY, 2025) | Gross profit N/A | Gross profit ₹54.1b (FY, 2026) |
Net income | Net income ($242m) (FY, 2025) | Net income N/A | Net income $1.3b (FY, 2025) | Net income N/A | Net income ₹6.7b (FY, 2026) |
Operating ⚠ | |||||
R&D Centers | R&D Centers N/A | R&D Centers N/A | R&D Centers N/A | R&D Centers 7 (Y, 2021) | R&D Centers 2 (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyChiesi Group
HQ
Parma, IT
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View companyAlembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View company